Merck’s strong oncology gains, 4% yield, and low PEG ratio support its value case despite sector risks and patent concerns.

Over the past decade, AbbVie's shares have increased by 353.3%, or 16.3% annually, with dividends reinvested. That's ...

Nvidia was edging down early on Monday as investors look ahead to its earnings report next week and weigh up reports on its ...

UnitedHealth extends gains while Dayforce soars following a report that says it could be bought by private-equity firm Thoma ...

Stock futures inched down Monday morning as market participants awaited a critical meeting in Washington between President ...

Dow, S&P 500, and Nasdaq futures are falling in premarket trading as the stock market braces for President Donald Trump's Ukraine meeting. The Federal Reserve's Jackson Hole Symposium and Retail ...

Technically, the counter trades higher than the 5-day, 20-day, 50-day and 100-day moving averages but lower than the 200-day ...

Stocks Set to Gain as Investors Await Ukraine Talks ...

An analyst from Master Capital said that Asian Paints has given a breakout from a double-bottom formation on the weekly chart ...

The market is expected to remain in consolidation mode until it reclaims all key moving averages. Below are some short-term trading ideas to consider.